Takeda Pharmaceutical - Buccolam - Ownership and Business Overview

Life ScienceCompany

Takeda Pharmaceutical - Buccolam Ownership

Who owns Takeda Pharmaceutical - Buccolam?

Takeda Pharmaceutical - Buccolam is owned by neuraxpharm Arzneimittel. It was acquired on September 14, 2020.

Takeda Pharmaceutical - Buccolam Business Overview

Where is Takeda Pharmaceutical - Buccolam headquartered?

Takeda Pharmaceutical - Buccolam is headquartered in Osaka, Japan.

What sector is Takeda Pharmaceutical - Buccolam in?

Takeda Pharmaceutical - Buccolam is a life science company.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 285 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 262 by strategics.

Takeda Pharmaceutical Co.,Ltd. - Buccolam

Osaka, 103-8668
Japan,

Takeda Pharmaceutical Co. Ltd. - Buccolam is the only buccal midazolam approved across Europe. This value-added product is indicated for the emergency treatment of epileptic children with prolonged acute convulsive seizures (PACS), the most common neurological emergency in children with an incidence of 18 to 23 cases per 100,000 per year.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Takeda Pharmaceutical - Buccolam

Life Science Companies , Japan Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Japan Companies

Largest Japan Companies , Acquisitive Japan Companies , Recently Acquired Japan Companies , Recently Sold Japan Companies , Private Japan Companies , Public Japan Companies , Acquired Japan Companies , PE Backed Japan Companies
Mergr

Product

Company

Legal